Discontinuation of Phyllocontin® (aminophylline) 225mg and 350mg Modified Release tablets

  • Home
  • News
  • Discontinuation of Phyllocontin® (aminophylline) 225mg and 350mg Modified Release tablets
NCL Wide
Add to CPD

Phyllocontin® has been discontinued in the UK based on a commercial decision; stock of the 225mg tablets is expected to be exhausted by 30 March 2021 and the 350mg tablets are expected to be exhausted by 5 April 2021.

NCL CCG has developed advice which summarises the Department of Health and Social Care Supply Disruption Alert. This integrates advice from respiratory specialists within NCL and advises on safe switching from Phyllocontin® for adults and paediatric patients, as well as the required monitoring.

Discontinuation of Phyllocontin® (aminophylline) 225mg and 350mg modified release tablets (NCL, March 2021)

Download PDF, 66.89 KB
Expiry date: May 25th, 2021